WEDBUSH SECURITIES INC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 62 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q1 2020$740,000
-2.4%
8,0000.0%0.09%
+31.3%
Q4 2019$758,000
+4.7%
8,0000.0%0.07%
-5.6%
Q3 2019$724,000
-1.1%
8,0000.0%0.07%
-4.1%
Q2 2019$732,000
-0.8%
8,0000.0%0.07%
-6.3%
Q1 2019$738,000
+2.2%
8,0000.0%0.08%
-14.1%
Q4 2018$722,000
-3.5%
8,0000.0%0.09%
+8.2%
Q3 2018$748,000
+0.8%
8,0000.0%0.08%
-7.6%
Q2 2018$742,000
+5.8%
8,0000.0%0.09%0.0%
Q1 2018$701,000
-0.1%
8,0000.0%0.09%
+7.0%
Q4 2017$702,000
-2.6%
8,0000.0%0.09%
-8.5%
Q3 2017$721,000
-16.0%
8,0000.0%0.09%
-15.3%
Q2 2017$858,000
-0.1%
8,0000.0%0.11%
-4.3%
Q1 2017$859,000
-1.9%
8,0000.0%0.12%
-10.1%
Q4 2016$876,000
-8.3%
8,0000.0%0.13%
-9.2%
Q3 2016$955,000
-4.8%
8,0000.0%0.14%
-13.4%
Q2 2016$1,003,000
-3.7%
8,0000.0%0.16%
-9.4%
Q1 2016$1,041,0008,0000.18%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q4 2017
NameSharesValueWeighting ↓
Western Asset Management Company, LLC 31,076,000$29,006,00023.36%
INCOME RESEARCH & MANAGEMENT 15,589,000$14,254,0007.13%
SYMPHONY ASSET MANAGEMENT LLC 17,600,000$16,378,0005.14%
PenderFund Capital Management Ltd. 8,470,000$11,097,0003.46%
Radcliffe Capital Management, L.P. 15,823,000$14,645,0002.75%
LMR Partners LLP 34,735,000$32,172,0001.50%
Bracebridge Capital, LLC 5,500,000$5,000,0000.91%
Penn Capital Management Company, LLC 5,079,000$4,701,0000.78%
ONTARIO TEACHERS PENSION PLAN BOARD 17,400,000$16,191,0000.44%
WESTWOOD HOLDINGS GROUP INC 29,605,000$27,715,0000.42%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders